A prospective study to evaluate whether serum kisspeptin is a marker predictive of the first-trimester miscarriage of women who conceive in IVF.

Published in: Journal of assisted reproduction and genetics (2023)

Serum kisspeptin on day 14 failed to discriminate between miscarriage and ongoing pregnancies, and days 21 and 28 had poor predictive values of miscarriage.

Keyphrases

pregnancy outcomes
polycystic ovary syndrome
pregnant women
preterm birth
type diabetes
metabolic syndrome
adipose tissue
insulin resistance
cervical cancer screening
breast cancer risk